Proteosome influenza vaccine

Details for Australian Patent Application No. 2001238478 (hide)

Owner ID Biomedical Corporation of Quebec

Inventors Plante, Martin; Fries, Louis F. III.; Burt, David S.; Jones, David Hugh; White, Gregory Lee; Lowell, George H; Torossian, Kirkor

Agent FB Rice

Pub. Number AU-B-2001238478

PCT Pub. Number WO01/60402

Priority 60182476 15.02.00 US

Filing date 15 February 2001

Wipo publication date 27 August 2001

Acceptance publication date 1 June 2006

International Classifications

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 39/145 (2006.01) Medicinal preparations containing antigens or antibodies - Orthomyxoviridae, e.g. influenza virus

A61K 39/295 (2006.01) Medicinal preparations containing antigens or antibodies - Polyvalent viral antigens

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

Event Publications

1 June 2006 Application Accepted

  Published as AU-B-2001238478

29 June 2006 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 30 May 2006. Address for service in Australia - FB Rice & Co Level 23 200 Queen Street MELBOURNE VIC 3000

28 September 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001238479-Intraocular lens manufacturing process

2001238477